To evaluate the effect of Zhichan granules on Parkinson's disease patients with liver and kidney deficiency and its influence on gut microbiota and metabolites.
A total of 74 patients were enrolled and randomly divided into treatment group and control group, with 37 cases in each group. The two groups received Zhichan granules and Zhichan granules placebo combined with conventional western medicine, respectively, for 12 weeks. The changes in the unified Parkinson's disease rating scale(UPDRS) and traditional Chinese medicine(TCM) syndrome scale scores were evaluated in both groups. The differences in gut microbiota and metabolites before and after treatment were observed and analyzed.
After treatment, the scores of UPDRSⅠ, Ⅲ, and Ⅳ sections and the TCM syndrome scale in the treatment group were improved compared with those before treatment and the control group at the same time point, with statistically significant differences(P<0.05). In the control group, there were no significant differences in the scores of UPDRSⅠ—Ⅳ sections and the TCM syndrome scale before and after treatment(P>0.05). There was no significant difference in α and β diversity of intestinal flora between the two groups before and after treatment(P>0.05). After treatment, the abundance of Pseudomonas, Prevotella, Morganella, Nocardioides and g_RCP2_54 increased in the treatment group. After treatment, 33 metabolites were up-regulated and 26 metabolites were down-regulated in the treatment group, while 2 metabolites were up-regulated and 8 metabolites were down-regulated in the control group. The pathway enrichment analysis showed that most of the differential metabolites in the treatment group may affect Parkinson's disease by regulating the biosynthesis of valine, leucine and isoleucine, linoleic acid metabolism and β-alanine metabolism.
After 12 weeks of administration, Zhichan granules can improve the mental and emotional state, motor ability and complications of PD patients, and also improve the TCM syndromes. Additionally, it can affect the gut microbiota and metabolites.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |